M. Kaya Et Al. , "Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.," Current eye research , vol.48, no.5, pp.498-505, 2023
Kaya, M. Et Al. 2023. Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.. Current eye research , vol.48, no.5 , 498-505.
Kaya, M., Atas, F., Kocak, N., Ozturk, T., Ayhan, Z., & Kaynak, S., (2023). Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.. Current eye research , vol.48, no.5, 498-505.
Kaya, Mahmut Et Al. "Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.," Current eye research , vol.48, no.5, 498-505, 2023
Kaya, Mahmut Et Al. "Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.." Current eye research , vol.48, no.5, pp.498-505, 2023
Kaya, M. Et Al. (2023) . "Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.." Current eye research , vol.48, no.5, pp.498-505.
@article{article, author={Mahmut Kaya Et Al. }, title={Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.}, journal={Current eye research}, year=2023, pages={498-505} }